Acquisition (Additional Information) (Details) - USD ($) $ in Thousands		12 Months Ended
	Nov. 01, 2021	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Business Acquisition [Line Items]
Escrow Deposit		$ 6,000
Escrow amount description		of the escrow amount was released in May 2023, and any remaining escrow amount will be released in May 2024
Net deferred taxes		$ 0	$ 3,095
Income tax benefit		(2,772)	(3,480)	$ 0
Recognized revenue		299,489	271,893	243,920
Net income (loss)		(311,656)	(217,490)	(183,619)
Class A Common Stock [Member]
Business Acquisition [Line Items]
Net income (loss)		(185,112)	(68,620)	$ (37,070)
Lemonaid Merger Agreement [Member]
Business Acquisition [Line Items]
Acquisition costs	$ 9,400
Lemonaid Health, Inc. [Member]
Business Acquisition [Line Items]
Stock based awards vested as of acquisition	8,400
Aggregate cash consideration for acquisition	101,900
Escrow Deposit		13,000
Amortization Expense		16,500	7,300
Acquired goodwill		$ 351,700
Goodwill Recognized, Description		The goodwill recognized upon acquisition is not expected to be deductible for income tax purposes.
Net deferred taxes	$ 6,600
Income tax benefit			3,500
Foreign deferred tax liability			3,100
Recognized revenue			19,200
Net income (loss)			$ 22,300
Lemonaid Health, Inc. [Member] | Selling, General and Administrative Expenses [Member]
Business Acquisition [Line Items]
Purchase Price Excludes Stock Consideration Shares Issued Subject to Vest	3,747,027
Lemonaid Health, Inc. [Member] | Selling, General and Administrative Expenses [Member] | Maximum [Member]
Business Acquisition [Line Items]
Useful lives		7 years
Lemonaid Health, Inc. [Member] | Selling, General and Administrative Expenses [Member] | Minimum [Member]
Business Acquisition [Line Items]
Useful lives		2 years
Lemonaid Health, Inc. [Member] | Lemonaid Merger Agreement [Member]
Business Acquisition [Line Items]
Purchase consideration	$ 424,700
Lemonaid Health, Inc. [Member] | Lemonaid Merger Agreement [Member] | Class A Common Stock [Member]
Business Acquisition [Line Items]
Additional common shares issuable in connection with acquisition	26,825,241
Purchase consideration stock value	$ 314,400